US 12351587
Bicyclic compound as RIP-1 kinase inhibitor and application thereof
granted A61PA61P29/00
Quick answer
US patent 12351587 (Bicyclic compound as RIP-1 kinase inhibitor and application thereof) held by Medshine Discovery Inc. expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P29/00